Mitsubishi Tanabe Estimates Data Forgery Will Cause Double-digit Profit Decline
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe expected a significant impact from a 25-day business halt ordered by Japanese regulators due to data forgery